aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with trovafloxacin in 1 studies
Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (trovafloxacin) | Trials (trovafloxacin) | Recent Studies (post-2010) (trovafloxacin) |
---|---|---|---|---|---|
253 | 100 | 17 | 466 | 47 | 43 |
Protein | Taxonomy | aluminum hydroxide, magnesium hydroxide, drug combination (IC50) | trovafloxacin (IC50) |
---|---|---|---|
Thromboxane-A synthase | Homo sapiens (human) | 4.023 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dogolo, LC; Friedman, HL; Teng, R; Vincent, J; Willavize, SA | 1 |
1 trial(s) available for aluminum hydroxide, magnesium hydroxide, drug combination and trovafloxacin
Article | Year |
---|---|
Effect of Maalox and omeprazole on the bioavailability of trovafloxacin.
Topics: Adult; Aluminum Hydroxide; Antacids; Anti-Infective Agents; Area Under Curve; Biological Availability; Drug Combinations; Fluoroquinolones; Humans; Magnesium Hydroxide; Male; Naphthyridines; Omeprazole | 1997 |